Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
Opexa Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 12, 2019
Opexa Therapeutics reported fiscal year 2018 executive compensation information on April 12, 2019.
In 2018, three executives at Opexa Therapeutics received on average a compensation package of $495K, a 45% decrease compared to previous year.
Average pay of disclosed executives at Opexa Therapeutics
Chris Schelling, Chief Executive Officer, received $550K in total, which decreased by 6% compared to 2017. 73% of Schelling's compensation, or $400K, was in salary. Schelling also received $150K in bonus.
William T. Andrews, M.D., FACP, Chief Medical Officer, received a compensation package of $505K, which decreased by 50% compared to previous year. 79% of the compensation package, or $400K, was in salary.
Harry Palmin, Chief Financial Officer, earned $429K in 2018, a 38% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 12, 2019.